In terms of anti-obesity mechanisms, activated AMPK phosphorylates and inhibits ACC, which consequently decreases malonyl-CoA, inhibiting fatty acid synthesis and simultaneously increasing mitochondrial β-oxidation [33,34,35]. Here, PRKAA1 is linked to obesity disorder.